LogicBio Therapeutics (LOGC) Misses Q3 EPS by 7c
Tweet
Share
E-mailGet Alerts LOGC Hot Sheet
Join SI Premium – FREE
LogicBio Therapeutics (NASDAQ: LOGC) reported Q3 EPS of ($0.07).
For earnings history and earnings-related data on LogicBio Therapeutics (LOGC) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- DocGo (DCGO) Misses Q2 EPS by 6c; Offers Guidance
- Nse Said To Seek Up To $55 Billion Valuation In India Ipo - Bloomberg
- UBS Downgrades Scor SE (SCR:FP) (SCRYY) to Sell
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
